[1]唐海玲 李嘉昕 李逢昌 史俊豪 张新峰 伍世恒.群体生物等效（PBE）统计方法用于微流控制备的脂质体产品粒径分布一致性的评价[J].大众科技,2020,22(12):37-40.
　Population Bioequivalence (PBE) Statistical Method for Evaluation of Particle Size Distribution Consistency of Liposomes Prepared by Microfluidic Control Chip[J].Popular Science & Technology,2020,22(12):37-40.
点击复制

群体生物等效（PBE）统计方法用于微流控制备的脂质体产品粒径分布一致性的评价()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
22
期数:
2020年12
页码:
37-40
栏目:
出版日期:
2020-12-20

文章信息/Info

Title:
Population Bioequivalence (PBE) Statistical Method for Evaluation of Particle Size Distribution Consistency of Liposomes Prepared by Microfluidic Control Chip
作者:
唐海玲1; 2 李嘉昕1 李逢昌1 史俊豪1 张新峰1 伍世恒3
（1.广西中医药大学药学院，广西 南宁 530200； 2.广西高校中药制剂共性技术研发重点实验室，广西 南宁 530200； 3.广州中医药大学第二附属医院，广东 广州 510120）
关键词:
群体生物等效统计分析方法; 脂质体; 粒径分布; 微流控技术
Keywords:
population bioequivalence statistical analysis method liposome particle size distribution microfluidic technology
文献标志码:
A
摘要:
由于脂质体产品的高变异性特点以及粒径对脂质体的体内分布、组织靶向行为、生物利用度的显著影响，本研究利用群体生物等效（PBE）统计方法评价微流控芯片技术连续制备的脂质体产品粒径分布的一致性。对比分析相同制备工艺参数下，不同分散介质的不同批次的脂质体产品粒径分布特点，以及不同储存温度下脂质体样品粒径随时间的变化规律。通过对脂质体样品粒径分布参数（D10，D50，D90，PDI）的细致对比研究，考察微流控芯片技术连续制备脂质体产品的批间差异和不同分散介质中（生理盐水，5%葡萄糖，水）脂质体粒径的稳定性。利用PBE统计方法可以更好的指导微流控芯片技术制备脂质体样品的处方工艺的优化筛选和稳定性研究。
Abstract:
Due to the high variability characteristics of liposome products and the influence of particle size on the distribution, tissue targeting behavior and clinical efficacy of liposomes, population bioequivalence (PBE) statistical method was selected to evaluate the consistency of particle size distribution of liposomes continuously prepared by microfluidic chip technology. The particle size distribution characteristics of different batches of liposome products under the same preparation process parameters in different dispersion medium were compared and analyzed, as well as the variation of the particle size of liposome samples with time under different storage temperature. Through the detailed comparative study of the size distribution parameters (D10, D50, D90, PDI) of liposome samples, the batch differences of continuous preparation of liposomes by microfluidic chip technology and the stability of liposome particle size in different dispersion media (normal saline, 5% glucose, water) were investigated. PBE statistical method can be used to guide the optimization of preparation process and stability research of liposome samples by microfluidic chip technology.

参考文献/References:

[1] Crommelin D J A, van Hoogevest P, Storm G. The role of liposomes in clinical nanomedicine development. What now? Now what? [J]. Journal of Controlled Release, 2020, 318: 256-263. [2] Kapoor M, Lee S L, Tyner K M. Liposomal drug product development and quality: current US experience and perspective[J]. The AAPS Journal, 2017, 19: 632-641. [3] Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems[J]. Pharmaceutics, 2018, 10(2): 57. [4] Tavakol S, Zare S, Hoveizi E, et al. The impact of the particle size of curcumin nanocarriers and the ethanol on beta_1-integrin overexpression in fibroblasts: A regenerative pharmaceutical approach in skin repair and anti-aging formulations[J]. DARU Journal of Pharmaceutical Sciences, 2019, 27: 159-168. [5] Peretz D S, Shamrakov D, Varenik M, et al. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes[J]. International Journal of Pharmaceutics, 2018, 547: 648-655. [6] Diaz D A, Colgan S T, Langer C S, et al. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations?[J]. The AAPS Journal, 2016, 18: 15-22. [7] Patil S M, Keire D A, Chen K. Comparison of NMR and dynamic light scattering for measuring diffusion coefficients of formulated insulin: implications for particle size distribution measurements in drug products[J]. The AAPS Journal, 2017, 19: 1760-1766. [8] Galgatte U C, Jamdade V R, Aute P P, et al. Study on requirements of bioequivalence for registration of pharmaceutical products in USA, Europe and Canada[J]. Saudi Pharmaceutical Journal, 2014, 22: 391-402. [9] Draft guidance on doxorubicin hydrochloride[Z]. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2014. [10] Guidance for industry: statistical approaches to establishing bioequivalence[Z]. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2001. [11] Li B V, Jin F, Lee S L, et al. Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approval[J]. The AAPS Journal, 2013, 15: 875-883. [12] Lu D, Lee S L, Lionberger R A, et al. International guidelines for bioequivalence of locally acting orally inhaled drug products: similarities and differences[J]. The AAPS Journal, 2015, 17: 546-557. [13] Hood R R, Vreeland W N, DeVoe D L, et al. Microfluidic remote loading for rapid single-step liposomal drug preparation[J]. Lab on a Chip, 2014, 14: 3359-3367. [14] Maeki M, Kimura N, Sato Y, et al. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems[J]. Advanced Drug Delivery Reviews, 2018, 128: 84-100. [15] Prabhakar A, Agrawal M, Mishra N, et al. Cost-effective smart microfluidic device with immobilized silver nanoparticles and embedded UV-light sources for synergistic water disinfection effects[J]. Rsc Advances, 2020, 10: 17479-17485. [16] Hamano N, Böttger R, Lee S E, et al. Robust microfluidic technology and new lipid composition for fabrication of curcumin-loaded liposomes: effect on the anticancer activity and safety of cisplatin[J]. Molecular Pharmaceutics, 2019, 16: 3957-3967.

备注/Memo

备注/Memo:
【收稿日期】2020-10-09 【基金项目】广西中医药大学校级博士课题科研启动基金项目（2019BS010）；广西高校中青年教师科研基础能力提升项目名单（2020KY0747）。 【作者简介】唐海玲（1982－），女，广西中医药大学助理研究员，研究方向为中药新剂型的研制和开发。
更新日期/Last Update: 2021-01-07